Articles related to DELUSIONS/HALLUCINATIONS

Explore the recent meta-analysis that delves into the potential of cholinesterase inhibitors in treating delusions and hallucinations in dementia patients. The findings reveal significant but clinically insignificant effects, highlighting the need for further research and targeted treatments.

This brief editorial introduces a series of articles describing the medical use of hallucinogens, ketamine, marijuana, and other agents — including the legal and ethical perspectives — in the treatment of various neurologic and psychiatric disorders.

In this case report, two Massachusetts psychiatrists, together with a radiologist and gerontologist, walk through the diagnosis and management of new onset neuropsychiatric symptoms following COVID infection.